標(biāo)題: Titlebook: Cardiovascular Outcomes Research; A Clinician’s Guide Kevin C. Maki,Don P. Wilson Book 2024 The Editor(s) (if applicable) and The Author(s [打印本頁] 作者: 機(jī)會 時間: 2025-3-21 17:11
書目名稱Cardiovascular Outcomes Research影響因子(影響力)
作者: 易于出錯 時間: 2025-3-21 21:05
2196-8969 scular Outcomes Research.?is a must-have resource for physicians and other clinicians, residents, fellows, and medical students in cardiology, endocrinology, primary care, and health promotion and disease preve978-3-031-54962-5978-3-031-54960-1Series ISSN 2196-8969 Series E-ISSN 2196-8977 作者: jealousy 時間: 2025-3-22 04:17
Pharmaceutical Development and Approval in the United States of Agents to Influence Cardiovascular H undertaking a Phase 3 trial to demonstrate efficacy for reducing the risk of clinical events, such as a trial to demonstrate a reduced risk of major adverse cardiovascular events (MACE), referred to as a cardiovascular outcomes trial (CVOT). Particular attention toward assessing the cardiovascular 作者: 有罪 時間: 2025-3-22 05:24
Biomarkers and Imaging Modalities to Detect Subclinical Atherosclerotic Cardiovascular Diseasevasive imaging tests better predicts major adverse cardiovascular events, especially in populations where the risk estimation may not be applicable (i.e., familial hypercholesterolemia), or where they may underestimate risk in some populations or overestimate risk in populations with protective risk作者: BRIEF 時間: 2025-3-22 08:42
An Overview of the Guideline Development Process for Atherosclerotic Cardiovascular Disease Risk Reded to present recommendations; this includes a table of the recommendations, synopsis, supporting text, and flow diagrams or additional tables for each “chunk” of information. The process of guideline development depends on the philosophy and instructional approach that is most representative of the作者: 使服水土 時間: 2025-3-22 15:49
Lifestyle Interventions and Atherosclerotic Cardiovascular Disease Outcomesatty acids and replace with unsaturated fatty acids; (3) limit intakes of foods and beverages with added sugars; (4) abstinence of alcohol for those who do not currently drink and limit alcohol intake to ≤1 drink/day for men and women who choose to drink; (5) participate in sufficient quantities and作者: 使服水土 時間: 2025-3-22 18:38
Inflammation and Cardiovascular Outcomes targets of inflammation aimed at reducing cardiovascular risk. The chapter also discusses the evidence behind anti-inflammatory therapies that are currently being studied in primary and secondary ASCVD prevention settings. Targeting inflammation has the potential to develop novel avenues to reduce 作者: Anticlimax 時間: 2025-3-22 21:32 作者: 疲憊的老馬 時間: 2025-3-23 01:51 作者: 劇毒 時間: 2025-3-23 06:39
Pharmacotherapy for Obesity: Recent Evolution and Implications for Cardiovascular Risk Reductionbesity is lifestyle intervention for weight loss, combined with the treatment of obesity-related cardiometabolic risk factors individually. The use of medications to treat obesity is relatively rare. In part, this reflects concerns about long-term safety and weight loss effectiveness, possible provi作者: MODE 時間: 2025-3-23 12:53 作者: 擴(kuò)音器 時間: 2025-3-23 14:22
Chronic Kidney Disease and Cardiovascular Outcomesrovide benefits to patients with CKD, they are controversial for outcomes in patients with end-stage kidney disease. Controlling blood pressure to a goal of <130/80 mm Hg is recommended in those with CKD. Smoking cessation, exercise, and a low salt diet have been associated with better outcomes in p作者: NICHE 時間: 2025-3-23 20:03
Primes and Algebraic Number Theory, undertaking a Phase 3 trial to demonstrate efficacy for reducing the risk of clinical events, such as a trial to demonstrate a reduced risk of major adverse cardiovascular events (MACE), referred to as a cardiovascular outcomes trial (CVOT). Particular attention toward assessing the cardiovascular 作者: irritation 時間: 2025-3-23 22:10 作者: adulterant 時間: 2025-3-24 04:57
Primality Testing: An Overview,ed to present recommendations; this includes a table of the recommendations, synopsis, supporting text, and flow diagrams or additional tables for each “chunk” of information. The process of guideline development depends on the philosophy and instructional approach that is most representative of the作者: NIB 時間: 2025-3-24 08:35
Uniform distribution and ergodic theory,atty acids and replace with unsaturated fatty acids; (3) limit intakes of foods and beverages with added sugars; (4) abstinence of alcohol for those who do not currently drink and limit alcohol intake to ≤1 drink/day for men and women who choose to drink; (5) participate in sufficient quantities and作者: occult 時間: 2025-3-24 11:00 作者: PAC 時間: 2025-3-24 17:53 作者: 名字的誤用 時間: 2025-3-24 21:57 作者: 離開真充足 時間: 2025-3-25 00:10 作者: 招惹 時間: 2025-3-25 03:47 作者: inscribe 時間: 2025-3-25 11:08 作者: 免費 時間: 2025-3-25 14:40 作者: 辮子帶來幫助 時間: 2025-3-25 17:12
Connections with number theory,he efficacy or effectiveness of lifestyle interventions. This chapter will summarize key challenges in developing evidence-based recommendations for non-pharmacological interventions for ASCVD risk reduction.作者: Decibel 時間: 2025-3-25 23:42 作者: fluffy 時間: 2025-3-26 00:08 作者: Arroyo 時間: 2025-3-26 05:19
Evolution of Cardiovascular Outcomes Studiesas myocardial infarction and stroke. Several study design components, including blinding, comparator groups, population, outcome variables, and follow-up durations, must be considered in the design and interpretation of a CVOT.作者: 北極人 時間: 2025-3-26 10:57
Statistical Methods for Cardiovascular Outcomes Studiesoaches; observational studies; randomized and target trials; statistical power; and sample size considerations. While not exhaustive, these fundamental topics are framed with functional examples in cardiology.作者: 職業(yè)拳擊手 時間: 2025-3-26 15:25 作者: 禁令 時間: 2025-3-26 17:23
The arithmetic of quadratic forms,ally on current and future therapies for lipid lowering. Our review is meant to assist in recognizing dyslipidemia in a clinical setting, identifying the most frequent causes of potential lipid derangements, and determining appropriate strategies to guide shared decision-making with the goal of reducing cardiovascular disease risk.作者: 奴才 時間: 2025-3-26 23:38
Implementation Science: Strategies to Improve Adoption and Adherence to Clinical Practice Guidelinesting implementation. Implementation science has been applied to the field of cardiology with recommendations for incorporation into guidelines. This chapter provides an overview of implementation science for improving adoption of and sustained adherence to evidence-informed recommendations in clinical practice.作者: precede 時間: 2025-3-27 01:08
Lipids, Lipoproteins, and Cardiovascular Outcomesally on current and future therapies for lipid lowering. Our review is meant to assist in recognizing dyslipidemia in a clinical setting, identifying the most frequent causes of potential lipid derangements, and determining appropriate strategies to guide shared decision-making with the goal of reducing cardiovascular disease risk.作者: Aprope 時間: 2025-3-27 06:27
Benjamin Fine,Gerhard Rosenbergeras myocardial infarction and stroke. Several study design components, including blinding, comparator groups, population, outcome variables, and follow-up durations, must be considered in the design and interpretation of a CVOT.作者: Figate 時間: 2025-3-27 11:12 作者: Extemporize 時間: 2025-3-27 13:36 作者: 吸引力 時間: 2025-3-27 18:36 作者: 露天歷史劇 時間: 2025-3-27 23:07
Kevin C. Maki,Don P. WilsonOffers a comprehensive overview of the historical context of cardiovascular epidemiology.Provides clinicians with the tools to interpret observational and interventional cardiovascular outcomes studie作者: GOUGE 時間: 2025-3-28 06:00 作者: obstinate 時間: 2025-3-28 06:30 作者: 補(bǔ)充 時間: 2025-3-28 13:54 作者: Metastasis 時間: 2025-3-28 17:47
978-3-031-54962-5The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Switzerl作者: 排斥 時間: 2025-3-28 22:12
Benjamin Fine,Gerhard Rosenberger outcomes, but these types of studies are vulnerable to confounding and bias. Randomized, controlled trials are a more effective approach for establishing cause-and-effect relationships. Cardiovascular outcome trials (CVOTs) are commonly used to evaluate the impact of interventions on outcomes such 作者: insightful 時間: 2025-3-29 02:04 作者: Ergots 時間: 2025-3-29 04:56 作者: PET-scan 時間: 2025-3-29 10:53 作者: 精致 時間: 2025-3-29 12:38
Primality Testing: An Overview,ent to improve patient care and cardiovascular outcomes. In the United States, ASCVD risk prevention and cholesterol management guidelines have evolved from those in the National Heart, Lung, and Blood Institute-sponsored Adult Treatment Panels I–III to those put forth by the American College of Car作者: 縱欲 時間: 2025-3-29 16:01 作者: COWER 時間: 2025-3-29 22:22
Connections with number theory,mmendations for non-pharmacological interventions can be challenging because of the complexities associated with conducting high-quality research on the efficacy or effectiveness of lifestyle interventions. This chapter will summarize key challenges in developing evidence-based recommendations for n作者: 搜集 時間: 2025-3-30 00:12 作者: 領(lǐng)帶 時間: 2025-3-30 05:32
The arithmetic of quadratic forms,tein metabolism caused by genetic and environmental factors can promote the development of atherosclerotic cardiovascular disease. Integrating guideline-recommended screening of lipid concentrations is a critical step to inform tailored lifestyle and pharmacotherapeutic management strategies and red作者: MELON 時間: 2025-3-30 11:52 作者: 創(chuàng)新 時間: 2025-3-30 14:46
https://doi.org/10.1007/0-387-29854-1nt of thromboembolism has considerable significance in contemporary clinical practice. Many pharmacological agents have been developed to treat thrombosis - the advent of newer catheterbased options has allowed minimally invasive catheter-based therapy to be provided safely to sick patients with low作者: 雄偉 時間: 2025-3-30 18:56 作者: arbiter 時間: 2025-3-30 22:42 作者: Dislocation 時間: 2025-3-31 01:26 作者: Instantaneous 時間: 2025-3-31 07:16
The functions of the linear sieve (summary),provides a contemporary review of common arrhythmic disease entities. It focuses on epidemiologic trends and the impact of cardiovascular intervention in mitigating the adversities associated with various arrhythmic disease states.作者: Ostrich 時間: 2025-3-31 09:26 作者: Magisterial 時間: 2025-3-31 16:10
Evolution of Cardiovascular Outcomes Studies outcomes, but these types of studies are vulnerable to confounding and bias. Randomized, controlled trials are a more effective approach for establishing cause-and-effect relationships. Cardiovascular outcome trials (CVOTs) are commonly used to evaluate the impact of interventions on outcomes such 作者: 黃瓜 時間: 2025-3-31 18:19
